Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 96

1.

Progressive disruption of cellular protein folding in models of polyglutamine diseases.

Gidalevitz T, Ben-Zvi A, Ho KH, Brignull HR, Morimoto RI.

Science. 2006 Mar 10;311(5766):1471-4. Epub 2006 Feb 9.

2.

Prion domains: sequences, structures and interactions.

Ross ED, Minton A, Wickner RB.

Nat Cell Biol. 2005 Nov;7(11):1039-44. Review.

PMID:
16385730
3.

Modulation of prion formation, aggregation, and toxicity by the actin cytoskeleton in yeast.

Ganusova EE, Ozolins LN, Bhagat S, Newnam GP, Wegrzyn RD, Sherman MY, Chernoff YO.

Mol Cell Biol. 2006 Jan;26(2):617-29.

4.

Prion variant maintained only at high levels of the Hsp104 disaggregase.

Borchsenius AS, Müller S, Newnam GP, Inge-Vechtomov SG, Chernoff YO.

Curr Genet. 2006 Jan;49(1):21-9. Epub 2005 Nov 24.

PMID:
16307272
5.

Functional amyloid formation within mammalian tissue.

Fowler DM, Koulov AV, Alory-Jost C, Marks MS, Balch WE, Kelly JW.

PLoS Biol. 2006 Jan;4(1):e6.

6.

The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death.

LeBlanc AC.

Curr Alzheimer Res. 2005 Oct;2(4):389-402. Review.

PMID:
16248844
7.

The Saccharomyces cerevisiae ESU1 gene, which is responsible for enhancement of termination suppression, corresponds to the 3'-terminal half of GAL11.

Ono B, Futase T, Honda W, Yoshida R, Nakano K, Yamamoto T, Nakajima E, Noskov VN, Negishi K, Chen B, Chernoff YO.

Yeast. 2005 Aug;22(11):895-906.

8.

Primary sequence independence for prion formation.

Ross ED, Edskes HK, Terry MJ, Wickner RB.

Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12825-30. Epub 2005 Aug 25.

9.

The formation of Escherichia coli curli amyloid fibrils is mediated by prion-like peptide repeats.

Cherny I, Rockah L, Levy-Nissenbaum O, Gophna U, Ron EZ, Gazit E.

J Mol Biol. 2005 Sep 16;352(2):245-52.

PMID:
16083908
10.

Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease.

Flower TR, Chesnokova LS, Froelich CA, Dixon C, Witt SN.

J Mol Biol. 2005 Sep 2;351(5):1081-100.

PMID:
16051265
11.

Yeast prions [URE3] and [PSI+] are diseases.

Nakayashiki T, Kurtzman CP, Edskes HK, Wickner RB.

Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10575-80. Epub 2005 Jul 15.

12.

Polyglycine expansions in eRF3/GSPT1 are associated with gastric cancer susceptibility.

Brito M, Malta-Vacas J, Carmona B, Aires C, Costa P, Martins AP, Ramos S, Conde AR, Monteiro C.

Carcinogenesis. 2005 Dec;26(12):2046-9. Epub 2005 Jun 29.

PMID:
15987717
13.

Structure of the cross-beta spine of amyloid-like fibrils.

Nelson R, Sawaya MR, Balbirnie M, Madsen AØ, Riekel C, Grothe R, Eisenberg D.

Nature. 2005 Jun 9;435(7043):773-8.

14.

Structural insights into a yeast prion illuminate nucleation and strain diversity.

Krishnan R, Lindquist SL.

Nature. 2005 Jun 9;435(7043):765-72.

15.

Prions as adaptive conduits of memory and inheritance.

Shorter J, Lindquist S.

Nat Rev Genet. 2005 Jun;6(6):435-50. Review.

PMID:
15931169
16.

Modulation of prion-dependent polyglutamine aggregation and toxicity by chaperone proteins in the yeast model.

Gokhale KC, Newnam GP, Sherman MY, Chernoff YO.

J Biol Chem. 2005 Jun 17;280(24):22809-18. Epub 2005 Apr 11.

17.
18.

Functional insights from the distribution and role of homopeptide repeat-containing proteins.

Faux NG, Bottomley SP, Lesk AM, Irving JA, Morrison JR, de la Banda MG, Whisstock JC.

Genome Res. 2005 Apr;15(4):537-51.

19.

Cellular prion protein neuroprotective function: implications in prion diseases.

Roucou X, LeBlanc AC.

J Mol Med (Berl). 2005 Jan;83(1):3-11. Epub 2004 Nov 10. Review.

PMID:
15645198
20.

Supplemental Content

Support Center